PubRank

Giuseppe Damante

Author PubWeight™ 79.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 2005 2.75
2 Subfunctionalization of duplicated zebrafish pax6 genes by cis-regulatory divergence. PLoS Genet 2008 1.59
3 Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 2005 1.33
4 Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009 1.23
5 APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res 2008 1.13
6 Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Oncol Rep 2001 1.08
7 Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors. J Clin Endocrinol Metab 2002 1.04
8 A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem J 2004 1.03
9 A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation. Am J Med Genet A 2007 1.03
10 Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors. Endocrinology 2005 1.02
11 A deletion 3' to the PAX6 gene in familial aniridia cases. Mol Vis 2007 1.01
12 Expression of Dicer and Drosha in triple-negative breast cancer. J Clin Pathol 2012 1.00
13 Epigenetics of thyroid cancer and novel therapeutic targets. J Mol Endocrinol 2011 0.98
14 HEX expression and localization in normal mammary gland and breast carcinoma. BMC Cancer 2006 0.98
15 Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: evidence for an autoregulatory loop. Free Radic Res 2005 0.98
16 Thyroid transcription factor-1 facilitates cerebrospinal fluid formation by regulating aquaporin-1 synthesis in the brain. J Biol Chem 2007 0.95
17 Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation. Biochem Biophys Res Commun 2003 0.93
18 Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors. Croat Med J 2008 0.93
19 TTF-1, a homeodomain-containing transcription factor, participates in the control of body fluid homeostasis by regulating angiotensinogen gene transcription in the rat subfornical organ. J Biol Chem 2003 0.93
20 Extracellular ATP stimulates the early growth response protein 1 (Egr-1) via a protein kinase C-dependent pathway in the human osteoblastic HOBIT cell line. Biochem J 2003 0.93
21 Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radic Res 2005 0.93
22 Expression of fetal hemoglobin in adult humans exposed to high altitude hypoxia. Blood Cells Mol Dis 2012 0.93
23 Functional interaction among thyroid-specific transcription factors: Pax8 regulates the activity of Hex promoter. Mol Cell Endocrinol 2004 0.92
24 Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatol 2002 0.90
25 Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts' response. Bone 2005 0.90
26 High periostin expression correlates with aggressiveness in papillary thyroid carcinomas. J Endocrinol 2008 0.89
27 Galectin-3 expression in non-small cell lung carcinoma. Cancer Lett 2004 0.89
28 Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. Leuk Res 2010 0.87
29 Thyroid-specific transcription factors control Hex promoter activity. Nucleic Acids Res 2003 0.86
30 Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1. Endocrinology 2003 0.86
31 Nucleophosmin is overexpressed in thyroid tumors. Biochem Biophys Res Commun 2010 0.86
32 Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia. J Hum Genet 2005 0.86
33 Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest 2002 0.86
34 Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation. Endocrine 2014 0.86
35 PTEN and Egr-1 expression in thyroid proliferative lesions. Cancer Lett 2004 0.85
36 Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain. J Biol Chem 2002 0.85
37 Nucleophosmin delocalization in thyroid tumour cells. Endocr Pathol 2011 0.85
38 BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. Am J Hematol 2013 0.85
39 Regulation of pituitary adenylate cyclase-activating polypeptide gene transcription by TTF-1, a homeodomain-containing transcription factor. J Biol Chem 2002 0.84
40 Targeting histone deacetylase in thyroid cancer. Expert Opin Ther Targets 2012 0.83
41 Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. Oncol Rep 2010 0.83
42 Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation. Thyroid 2009 0.83
43 Markers of the uPA system and common prognostic factors in breast cancer. Am J Clin Pathol 2007 0.83
44 Identification of the first deletion in the LRP5 gene in a patient with autosomal dominant osteopetrosis type I. Bone 2011 0.82
45 Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse. Cancer 2010 0.82
46 Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells. Endocrinology 2004 0.82
47 DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells. Int J Cancer 2009 0.82
48 Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. BMC Cancer 2014 0.82
49 Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects. J Thromb Thrombolysis 2007 0.82
50 Molecular analysis of a human PAX6 homeobox mutant. Eur J Hum Genet 2006 0.82
51 Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest 2003 0.82
52 A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization. Clin Endocrinol (Oxf) 2010 0.81
53 Differential proteomic analysis of nuclear extracts from thyroid cell lines. J Chromatogr B Analyt Technol Biomed Life Sci 2006 0.81
54 Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers. Biochem Biophys Res Commun 2012 0.81
55 TTF-1 regulates growth hormone and prolactin transcription in the anterior pituitary gland. Biochem Biophys Res Commun 2007 0.81
56 Levels of histone acetylation in thyroid tumors. Biochem Biophys Res Commun 2011 0.80
57 Expression, regulation, and function of paired-box gene 8 in the human placenta and placental cancer cell lines. Endocrinology 2005 0.80
58 Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma. Pathol Res Pract 2010 0.80
59 Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. J Mol Endocrinol 2014 0.80
60 Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway. J Cell Physiol 2006 0.79
61 Thyroid transcription factor-1 regulates feeding behavior via melanocortin pathway in the hypothalamus. Diabetes 2011 0.79
62 Two novel NPM1 mutations in a therapy-responder AML patient. Hematol Oncol 2010 0.79
63 The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. Mol Cell Endocrinol 2012 0.79
64 One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis. Virchows Arch 2013 0.79
65 A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. Clin Endocrinol (Oxf) 2013 0.79
66 Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation. Mol Cell Biochem 2009 0.79
67 CASR gene activating mutations in two families with autosomal dominant hypocalcemia. Mol Genet Metab 2012 0.79
68 Investigation of endothelin-1 type A receptor gene polymorphism (-231 G > A) in preeclampsia susceptibility. J Matern Fetal Neonatal Med 2007 0.78
69 Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. Endocrinology 2013 0.78
70 Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections. J Oral Pathol Med 2013 0.78
71 Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene. Mol Biol Rep 2014 0.78
72 Histone post-translational modifications associated to BAALC expression in leukemic cells. Biochem Biophys Res Commun 2011 0.78
73 Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. Thyroid 2012 0.78
74 TTF-1 action on the transcriptional regulation of cyclooxygenase-2 gene in the rat brain. PLoS One 2011 0.77
75 A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification. Genet Test Mol Biomarkers 2009 0.77
76 Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy. Anticancer Drugs 2012 0.77
77 Quick MLPA test for quantification of SMN1 and SMN2 copy numbers. Mol Cell Probes 2010 0.77
78 Unexpected phenotype of a typical NPM1 mutant. Br J Haematol 2009 0.77
79 Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer. Oncology 2002 0.77
80 Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. Neuromuscul Disord 2009 0.76
81 Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. Oncol Rep 2011 0.76
82 Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. Haematologica 2012 0.76
83 Using the recognition code to swap homeodomain target specificity in cell culture. Mol Biol Rep 2011 0.76
84 Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia. Semin Thromb Hemost 2011 0.76
85 Helix mobility and recognition function of the rat thyroid transcription factor 1 homeodomain - hints from 15N-NMR relaxation studies. FEBS J 2007 0.76
86 In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription. Cell Oncol (Dordr) 2011 0.76
87 PAX8 expression in human bladder cancer. Oncol Rep 2006 0.76
88 Proteomic evaluation of core biopsy specimens from breast lesions. Cancer Lett 2004 0.75
89 Association between low-activity allele of cathecolamine-O-methyl-transferase (COMT) and Borderline Personality Disorder in an Italian population. Behav Med 2013 0.75
90 BRCA2 germline mutations in primary cancer of the fallopian tube. Oncol Rep 2004 0.75
91 A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient. Cancer Lett 2003 0.75
92 TTF-1 positivity in 2 cases of adenocarcinoma of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 2014 0.75
93 Microdeletion 15q26.2qter and Microduplication 18q23 in a Patient with Prader-Willi-Like Syndrome: Clinical Findings. Cytogenet Genome Res 2016 0.75
94 Conservation across species identifies several transcriptional enhancers in the HEX genomic region. Mol Cell Biochem 2009 0.75